Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 4Recruiting 3Completed 3Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Gynecologic 3Genitourinary 1Dermatologic 1

Conditions

Ovarian Neoplasms 2Vulvar Neoplasms 1Ovarian Germ Cell Cancer 1

Interventions

Paclitaxel 79Carboplatin 66pembrolizumab 61Bevacizumab 56Cisplatin 48Specimen Handling 29Drug Therapy 26Blood Specimen Collection 24Cyclophosphamide 20olaparib 19Taxes 17Magnetic Resonance Spectroscopy 16Letrozole 16Gemcitabine 16Biopsy 16liposomal doxorubicin 15niraparib 14fludarabine 14Brachytherapy 14Radiotherapy 13abemaciclib 12Topotecan 11Nivolumab 11Injections 11Doxorubicin 11lenvatinib 10Fluorouracil 10atezolizumab 9Surveys and Questionnaires 9Standard of Care 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Bleomycin × Gynecologic × Clear all
NCT02429687 2023-04-25

MOGCT-01

Shandong University

Phase 3 Recruiting
129 enrolled
Gynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms

NCT02429700 2023-04-25

SCST-01

Shandong University

Phase 3 Recruiting
132 enrolled
Gynecologic

Ovarian Neoplasms

NCT05395962 2022-05-27

Elechtra

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase 2 Recruiting
92 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡